Post-COVID Lung Disease Shares Origins with Other Scarring Lung Disorders
July 20, 2022
UC San Diego researchers provide first insights into the fundamental cellular pathologies that drive interstitial lung disease in patients post-COVID.
July 20, 2022
UC San Diego researchers provide first insights into the fundamental cellular pathologies that drive interstitial lung disease in patients post-COVID.
December 23, 2021
UC San Diego engineers developed a powerful new tool that directly measures the movement and speed of electrical signals inside heart cells, using tiny “pop-up” sensors that poke into cells without damaging them. It could be used to gain more detailed insights into heart disorders and diseases.
January 16, 2020
Two different UC San Diego research teams identified the same molecule — αvβ5 integrin — as Zika virus’ key to brain cell entry. They found ways to take advantage of the integrin to both block Zika virus from infecting cells and turn it into something good: a way to shrink…
November 1, 2022
Researchers at UC San Diego School of Medicine and Moores Cancer Center at UC San Diego Health describe the first preclinical model of appendiceal cancer that contains all elements of the tumor, allowing previously stymied investigations to proceed.
January 31, 2023
The evolution of clinical trials is accelerating, driven by emerging technologies, social imperatives and the next public health crisis.
January 30, 2019
In a study published January 17, 2019 in Translational Psychiatry, researchers at University of California San Diego School of Medicine describe how, in a novel mouse model, epigenetic regulation negatively impacts a downstream gene specifically involved in neurodevelopment and associated behaviors.
December 1, 2022
The California Institute for Regenerative Medicine has awarded UC San Diego researchers $4.8 million to advance a gene therapy to treat Friedreich’s ataxia, a rare but devastating neuromuscular disorder.
June 28, 2023
UC San Diego researchers find a combination of drugs outperformed other treatments in human and mouse models of pancreatic cancer; now urge clinical trial
October 18, 2022
Two early career researchers at the University of California San Diego have been named recipients of the 2022 National Institutes of Health (NIH) Director’s New Innovator Award from the NIH Common Fund’s High-Risk, High-Reward Research program.
March 7, 2023
At the 2023 South by Southwest(SXSW) conference, which runs March 10-14, scientists and leaders from UC San Diego will contribute their expertise to programming on climate change, space, health, and blue technology.